Wisconsin Alumni Research Foundation

WT-7695 delivers 8x more radiation to tumors

Superior off-rate translated to greater in vivo tumor uptake, retention and efficacy

  • 55 %IA/g delivered to tumor at 24 hours
  • 18 %IA/g retained in tumor at 7 days
  • WT-7695 is 8x more potent than DPI-4452

Study in ccRCC mouse model

To learn more, contact John Nagel or connect with us on the BIO partnering site.

Download the pitch deck

WARF